We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$299M
AUM Growth
-$7.34M
Cap. Flow
-$6.4M
Cap. Flow %
-2.14%
Top 10 Hldgs %
79.82%
Holding
71
New
4
Increased
2
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
AXLA
Axcella Health Inc. Common Stock
AXLA
+$1.9M
2
PAYO icon
Payoneer
PAYO
+$1.86M
3
PCOR icon
Procore
PCOR
+$940K
4
RKLB icon
Rocket Lab Corp
RKLB
+$417K
5
LZ icon
LegalZoom.com
LZ
+$397K

Top Sells

Rank Stock Value
1
GTM
ZoomInfo Technologies
GTM
+$8.07M
2
PLRX icon
Pliant Therapeutics
PLRX
+$1.35M
3
STRY
Starry Group Holdings, Inc.
STRY
+$993K
4
RVMD icon
Revolution Medicines
RVMD
+$869K
5
FLYW icon
Flywire
FLYW
+$394K

Sector Composition

Rank Sector Weight
1 Technology 66.46%
2 Consumer Discretionary 14.25%
3 Healthcare 12.61%
4 Communication Services 2.06%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOST icon
1
Toast
TOST
$18.8B
$41.2M 13.79%
2,282,878
– –
NABL icon
2
N-able
NABL
$818M
$38.2M 12.81%
3,719,600
– –
W icon
3
Wayfair
W
$12.5B
$34.9M 11.7%
1,062,126
– –
SWI
4
DELISTED
SolarWinds Corporation Common Stock
SWI
$34.8M 11.66%
3,719,600
– –
AVDX
5
DELISTED
AvidXchange
AVDX
$33.7M 11.28%
3,387,792
– –
MNDY icon
6
monday.com
MNDY
$3.68B
$22.2M 7.44%
181,953
– –
OMGA
7
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$15.1M 5.06%
2,647,059
– –
YMM icon
8
Full Truck Alliance
YMM
$9.64B
$7.66M 2.57%
957,580
– –
SOND
9
DELISTED
Sonder
SOND
$5.58M 1.87%
225,114
– –
EVLO
10
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$4.93M 1.65%
153,175
– –
HAPN
11
Happen Inc
HAPN
$2.19B
$4.52M 1.51%
513,440
– –
RLAY icon
12
Relay Therapeutics
RLAY
$3.99B
$4.43M 1.48%
296,402
– –
PAYO icon
13
Payoneer
PAYO
$2.42B
$3.92M 1.31%
717,416
+296,778
+71% +$1.86M
BE icon
14
Bloom Energy
BE
$47.5B
$3.1M 1.04%
162,199
– –
SQSP
15
DELISTED
Squarespace, Inc.
SQSP
$3.08M 1.03%
138,839
– –
NEUE
16
DELISTED
NeueHealth
NEUE
$2.74M 0.92%
52,721
– –
IAS
17
DELISTED
Integral Ad Science
IAS
$2.68M 0.9%
305,298
– –
NARI
18
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.45M 0.82%
38,540
– –
FTCH
19
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$2.09M 0.7%
442,716
– –
AXLA
20
DELISTED
Axcella Health Inc. Common Stock
AXLA
$2.04M 0.68%
248,317
+73,171
+42% +$1.9M
AMPL icon
21
Amplitude
AMPL
$1.16B
$1.85M 0.62%
153,018
– –
IBRX icon
22
ImmunityBio
IBRX
$7.3B
$1.7M 0.57%
335,709
– –
DOCS icon
23
Doximity
DOCS
$3.85B
$1.67M 0.56%
49,804
– –
HNST icon
24
The Honest Company
HNST
$421M
$1.43M 0.48%
475,629
– –
SPOT icon
25
Spotify
SPOT
$105B
$1.32M 0.44%
16,766
– –
1
2 3

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Harbourvest Partners held 71 positions worth $299M, down 2.4% from $306M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Harbourvest Partners's Q4 2022 filing shows 4 new, 2 increased, 1 reduced and 6 closed positions. Its largest new stake was Procore: 18,414 shares worth $869K. The largest sale was ZoomInfo Technologies, an estimated $8.07M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 61% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Harbourvest Partners's largest Q4 2022 buy was Procore: 18,414 shares worth $869K.
  • Harbourvest Partners added most to Axcella Health Inc. Common Stock in Q4 2022, an estimated $1.9M increase.
  • Harbourvest Partners's biggest Q4 2022 reduction was ZoomInfo Technologies, cutting an estimated $8.07M.
  • Harbourvest Partners fully exited Pliant Therapeutics in Q4 2022, selling an estimated $1.35M.
  • Harbourvest Partners's ten largest holdings make up 80% of its $299M portfolio in Q4 2022.
  • Harbourvest Partners opened 4 new positions and closed 6 in Q4 2022.
  • Harbourvest Partners's portfolio value fell 2.4% quarter-over-quarter to $299M.

Based on Harbourvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.